Telemedicine Follow-up for Post-ACS Patients

Tomsk National Research Medical Center of the Russian Academy of Sciences

Status: Completed

Conditions: ACS - Acute Coronary Syndrome

Treatments: Other: Telemedicine FU; Other: Office FU

Study type: Interventional

Funder types: Other

Identifiers

NCT04485754

TeleFU

Details and patient eligibility

About

The aim is to compare the safety of using telemedicine and office visit follow-up in post-acute coronary syndrome patients

Full description

Rehabilitation after acute coronary syndrome includes visits to the cardiologist's office at 1, 2, 6 and 12 months after discharge. Due to the Covid-19 pandemic, visiting a cardiologist's office maybe impossible. In such cases telemedicine follow-up visit would be reasonable choice. Taking into account the absence of studies in this area, providing investigation evaluating parameters of safety for both methodics is relevant.

Enrollment: 88 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Signed informed consent
2. Age ≥ 40 years
3. PCI with coronary artery stenting for ACS
4. Angiographic success PCI

Exclusion criteria

1. Patients with cancer
2. Severe CHF (EF LV <35% or functional class of heart failure III-IV NYHA)
3. Severe valvular heart disease or Prosthetic heart valves.
4. Severe forms of CKD (GFR<30mL/min)
5. Planned staged revascularization during the next 12 months
6. Planned surgery within the next 12 months

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

88 participants in 2 patient groups

Telemedicine FU

Experimental group

Description:

Telemedicine follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital.

Treatment:

Other: Telemedicine FU

Office FU

Active Comparator group

Description:

Office follow-up visit at 1, 3, and 6 months or 1 and 6 months after discharge from hospital.

Treatment:

Other: Office FU